Juvenescence Ltd - Apr 25, 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Director, 10%+ Owner
Signature
/s/ Gregory Bailey, Executive Chairman of Juvenescence Ltd.
Stock symbol
AGE
Transactions as of
Apr 25, 2023
Transactions value $
$0
Form type
4
Date filed
5/18/2023, 04:00 PM
Previous filing
Mar 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Warrant to Purchase Common Stock Award $0 +756K $0.00 756K Apr 25, 2023 Common Stock 756K $0.66 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in connection with the draw of loan funds under an Amended and Restated Secured Convertible Promissory Note between the issuer and the reporting person.
F2 The warrants are exercisable for shares of the issuer's common stock upon issuance.

Remarks:

Director by deputization